Skip to content
★ Sign in to follow
CP

China Pharma Holdings, Inc. Stock: price and insider trades · United States

US·Mcap US$28.8MHealth Care

China Pharma Holdings, Inc.: what insiders have been doing

We have very little insider data for China Pharma Holdings, Inc. so far: the most recent filing dates from 19 October 2023. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
13
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 25,421 of 26,911 companies
16.3
score / 100
Value
28
Quality
5
FCF yld0.0%
Earn yld-11%
EV/EBITDA·
ROE-21%
Gross mgn-3.2%
Net mgn-77%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$0.67
Analyst consensus
·
Income statement
RevenueUS$4.1M
Gross profit-US$132k-3% margin
EBITDA-US$1.5M-36% margin
Net income-US$3.2M-114.3% margin
Valuation
P/Book0.8x
Beta1.05
Balance sheet & cash
Market capUS$28.8M
Total debtUS$3.9M
Free Cash FlowUS$11k
Debt / Equity11%
Profitability & ownership
ROE-21.0%
ROA-9.4%
% insiders89.6%
% institutions0.5%
Last declaration on 19 October 2023
Declarations13 total
  • ◆
    CEO & Interim CFOExecutives
    2M USD28SEC
    13,757,063 shares@ US$0.1464.6% of flowCommon StockSEC:0001013762-23-005114:0
  • ◆
    CEO & Interim CFOExecutives
    1M USD26SEC
    1,760,000 shares@ US$0.6735.4% of flowCommon StockSEC:0001213900-21-047830:0
  • ◆
    CEO and interim CFOExecutives
    0SEC
    2,000,000 shares0Common StockSEC:0001213900-21-001170:0
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    100,000 shares0Common StockSEC:0001010549-12-000445:0
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    25,000 shares0Common StockSEC:0001010549-11-000526:0
  • ◆
    President and CEOExecutives
    0SEC
    50,000 shares0Common StockSEC:0001010549-11-000528:0
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    6,863 shares0Common StockSEC:0001010549-11-000198:0
  • ◇
    Chief Financial OfficerExecutives
    0SEC
    4,052 sharesCommon StockSEC:0001010549-10-000745:0
  • ◆
    DirectorExecutives
    5M USD0SEC
    1,500,000 shares@ US$3.00Common Stock, par value $0.001 per shareSEC:0001010549-10-000082:0
  • ◆
    DirectorExecutives(filed)
    7M USD0SEC
    4,465,734 shares@ US$1.52Common Stock, par value $0.001 per shareSEC:0001010549-07-000910:0
  • ◆
    DirectorExecutives
    0SEC
    10,000,000 sharesCommon Stock, par value $0.001 per shareSEC:0001010549-06-000620:0
  • ◆
    President and CEOExecutives
    0SEC
    10,000,000 sharesCommon Stock, par value $0.001 per shareSEC:0001010549-06-000619:0
  • ◆
    DirectorExecutives
    0SEC
    4,723,056 shares0Common StockSEC:0000899797-06-000189:0

13 of 13 declarations

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a company focused on the health and pharmaceutical sector. It is listed on NASDAQ under the ticker XNAS.